| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $95.3M | +36.0% |
| Cost of Revenue | $70.0M | +37.6% |
| Gross Profit | $25.2M | +31.9% |
| R&D Expense | $11.3M | +61.8% |
| SG&A Expense | $66.2M | +28.7% |
| Operating Income | -$52.3M | -33.0% |
| Net Income | -$39.3M | -4.7% |
| EPS (Basic) | -$7.09 | +87.4% |
| EPS (Diluted) | -$7.09 | +87.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $16.8M | -7.5% |
| Inventory | $40.4M | +5.0% |
| Current Assets | $60.1M | -7.3% |
| Total Assets | $83.9M | +6.3% |
| Current Liabilities | $50.7M | +140.9% |
| Total Liabilities | $54.2M | +157.4% |
| Stockholders' Equity | $29.7M | -48.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.3M | +43.7% |
| Capital Expenditures | $5.1M | -54.9% |
| Investing Cash Flow | -$5.0M | +55.3% |
| Financing Cash Flow | $37.4M | -54.8% |
| Free Cash Flow | -$42.4M | +45.3% |